Avalyn Pharma Begins IPO Process For Pulmonary Fibrosis Pipeline

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
European Medical Journal

Inhaled Therapy Targets Lung Inflammation After Infection

A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...
Technology Networks

Inhaled Therapy Targets Lung Infection Damage

A new inhaled therapy targets ANGPTL4 to reduce lung inflammation, fluid buildup, and scarring after infections. Preclinical ...
Rolling Out

What to know about idiopathic pulmonary fibrosis

When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...
Rolling Out

Understanding idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely compromises ...
Healio

Pulmonary rehabilitation improves training in cystic fibrosis lung transplant candidates

Please provide your email address to receive an email when new articles are posted on . Researchers captured exercise capacity measures during the first week of pulmonary rehabilitation to the session ...
The Impartial Reporter

Teague family donation supports Pulmonary Fibrosis NI work

Pulmonary Fibrosis NI has received a donation of €1,210 made in memory of the late Bart Teague. The cheque was presented by ...